Home / Centers & Institutes / Tulane Cancer Center / Research / Office of Clinical Research / Clinical Trials Study Finder / Head & Neck
Soligenix
A Pivotal, Double-Blind, Randomized, Placebo-Controlled, Multinational Study of SGX942 (Dusquetide) for the Treatment of Oral Mucositis in Patients Being Treated with Concomitant Chemoradiation for the Treatment of Squamous Cell Carcinoma of the Head and Neck (Protocol Number: IDR-OM-02)